benefit of two of the newer drugs for osteoporosis
There's good news about the benefit of two of the newer drugs for osteoporosis...Evista (raloxifene) and Fosamax (alendronate).
Evista is a selective estrogen receptor modulator (SERM). Lilly markets it now in the U.S...soon in Canada.
Evista has now been shown to prevent FRACTURES...initially it was shown just to increase bone density.